Why the study?
Identifying patients with HCM who may benefit from primary prevention with an ICD remains challenging, as current European and American risk stratification strategies have limitations.
Design
Review
Key result
Personalized sudden cardiac death risk stratification in hypertrophic cardiomyopathy integrates conventional scores, advanced phenotyping, and patient preferences to guide ICD implantation.
Authors
Loading...
May guide individualized ICD decisions in HCM; leaves open prospective validation of integrated models.
SCD risk stratification in HCM requires a personalized approach integrating conventional scores, advanced phenotyping, and shared decision-making.
Costantino et al. (2026) conducted a review in Hypertrophic Cardiomyopathy. Risk stratification strategies was evaluated. Personalized sudden cardiac death risk stratification in hypertrophic cardiomyopathy integrates conventional scores, advanced phenotyping, and patient preferences to guide ICD implantation.